{
  "slug": "hpv-cervical-carcinoma",
  "edition": "consensus_consistency_audit_2026-10-09 revised",
  "authoring_model": "Sol 6.1",
  "adversarial_reviewer": "Claude Opus 5.5 (Anthropic)",
  "review_date": "2026-10-14",
  "round": 2,
  "level_before": "Θ",
  "level_after": "Θ",
  "confidence_before": "High",
  "confidence_after": "High",
  "pmids_checked": 26,
  "pmids_failed": 0,
  "claims_spot_checked": 24,
  "claims_failed": 0,
  "findings_by_severity": {
    "Critical": 0,
    "Major": 0,
    "Minor": 1,
    "Editorial": 0
  },
  "findings": [
    {
      "id": "AR-1",
      "severity": "Minor",
      "regression": false,
      "type": "collective_author",
      "location": "REFERENCES 6, 7, 15 and the matching score-card citation-ledger rows",
      "original": "Group et al. / Network et al. / Sanjose et al.",
      "corrected": "FUTURE II Study Group / Cancer Genome Atlas Research Network / de Sanjose et al.",
      "evidence": "PubMed records the first author of PMID 17494925 as CollectiveName 'FUTURE II Study Group' and of PMID 28112728 as 'Cancer Genome Atlas Research Network'; the builder kept only the final word. PMID 20952254 is 'de Sanjose S', particle dropped; the review's own Red-Team Synthesis Note already writes 'de Sanjose'."
    }
  ],
  "rejected_findings": [
    "'The earlier adversarial approval refers to its original edition': VERIFIED TRUE for this case and left unchanged. The original edition carries an adversarial-review banner and approval section dated 2026-10-06 at deliverables/prepublication-enrichment-2026-10-05/website-series/hpv-cervical-carcinoma/review-addendum.md.",
    "Theta vs Omega: the Omega descriptor requires necessity AND sufficiency; sufficiency is biologically false since most infections clear. Structural block, correctly reasoned.",
    "Theta vs Eta: remaining exceptions are small, mapped and predicted by the histotype-mixture model.",
    "Circularity-safe restatement: a legitimate scope restriction under the v5.3 outcome-scope rule, since site and morphology are fixed before the HPV result.",
    "Aggregation: primary-subclaim on SC2 returns Theta; scope-matched also Theta because SC2's scope is the central claim's scope; weakest-link Eta. All three printed values correct.",
    "Eight-line independence audit: survives the v5.2 shared-failure test and applies it against itself (FUTURE II + PATRICIA merged; two England papers merged; three cell studies merged; two IECC papers merged).",
    "'Best model' field naming the nominal: not the renderer defect, the field is labelled 'Best model' and the nominal rank is stated adjacently; scorecard agrees.",
    "Momentum 'Mechanistic only': conservatively assigned against a real active phase I trial, with the reason the trial cannot cross the next threshold stated.",
    "Confidence High: rationale never leaned on access depth; unaffected by the lead's two-step policy.",
    "Chen 12.4%/0.14% and TCGA 169/178, 7/9: full-text-only figures, already disclosed and flagged by the review; consistent with, not contradicted by, the abstracts.",
    "PubMed title typo in PMID 40347270 ('squamous sell carcinoma') silently corrected by the review: rejected per the title-field convention.",
    "Print/e-pub year plus-or-minus 1 differences: rejected per convention."
  ],
  "residual_limitations": [
    "Ten of 26 sources read at abstract/metadata depth, including the Scotland registry study added by the red team.",
    "The two full-text-only sub-figures remain unverified by this reviewer; PMC does not serve the Chen full text.",
    "provenance_header.generated_by reads 'HSEF v5.4 evidence-gated review workflow' rather than naming Sol 6.1 (package-wide field, left for the lead)."
  ],
  "validator": {
    "result": "PASS",
    "fails": 0,
    "warns": 0,
    "passes": 33,
    "pre_review_validator": "none present in the revised case folder"
  },
  "files_changed": [
    "hpv-cervical-carcinoma.review.md",
    "hpv-cervical-carcinoma.scorecard.json",
    "validator.txt"
  ],
  "lead_artifact_sweep": {
    "false_approval_boilerplate": "present and TRUE for this case; verified against the original edition and left unchanged",
    "confidence_from_access_depth": "not present",
    "best_supported_rival_renderer_bug": "not applicable; field is labelled 'Best model' with the nominal rank stated separately",
    "reviewer_notes_consensus_contradiction": "not present",
    "momentum_decisive_work_underway": "not used; 'Mechanistic only' assigned against a real active trial",
    "collective_author_defect": "present in a truncating form ('Group et al.', 'Network et al.') that a leading-comma grep will miss"
  },
  "consensus_questions": [
    "What proportion of independently, morphology-first classified cervical squamous cell carcinomas are genuinely HPV-independent when tested with orthogonal DNA, RNA and p16 assays?"
  ]
}